amantadine has been researched along with Peripheral Nervous System Diseases in 9 studies
amant: an antiviral compound consisting of an adamantane derivative chemically linked to a water-solube polyanioic matrix; structure in first source
Peripheral Nervous System Diseases: Diseases of the peripheral nerves external to the brain and spinal cord, which includes diseases of the nerve roots, ganglia, plexi, autonomic nerves, sensory nerves, and motor nerves.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The effects of amantadine from one randomised, double-blind, placebo-controlled, cross-over trial comparing amantadine with placebo for the treatment of fatigue in 80 people with Guillain-Barré syndrome (GBS) were uncertain for the proportion of people achieving a favourable outcome six weeks post-intervention (odds ratio (OR) 0." | 4.90 | Interventions for fatigue in peripheral neuropathy. ( Garssen, MP; Stockley, RC; van Doorn, PA; White, CM, 2014) |
| "We report a 48-year-old woman with a 17-year history of PD who developed a peripheral sensory-motor neuropathy secondary to chronic administration (8 years) of amantadine." | 1.30 | Amantadine-induced peripheral neuropathy. ( Minagar, A; Sharma, K; Shulman, LM; Weiner, WJ, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 5 (55.56) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Childers, WE | 1 |
| Baudy, RB | 1 |
| Zhang, D | 1 |
| Geng, H | 1 |
| Cao, L | 1 |
| Li, W | 1 |
| White, CM | 1 |
| van Doorn, PA | 1 |
| Garssen, MP | 1 |
| Stockley, RC | 1 |
| Chrissafidou, A | 1 |
| Musch, E | 1 |
| Karadag, HC | 1 |
| Ulugol, A | 1 |
| Tamer, M | 1 |
| Ipci, Y | 1 |
| Dokmeci, I | 1 |
| Inomata, S | 1 |
| Kakiuchi, Y | 1 |
| Miyabe, M | 1 |
| Ohara, Y | 1 |
| Sukegawa, I | 1 |
| Osaka, Y | 1 |
| Kohda, Y | 1 |
| Toyooka, H | 1 |
| Shulman, LM | 1 |
| Minagar, A | 1 |
| Sharma, K | 1 |
| Weiner, WJ | 1 |
| Swerdloff, MA | 1 |
| Tarras, SC | 1 |
| Lance, JW | 1 |
| Andrews, C | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Randomized Controlled Phase II, Two-Arm Study of Umbilical Cord Blood Cell Transplant (MC001) Into Injured Spinal Cord Followed by the Locomotor Training for Patients With Chronic Complete Spinal Cord Injuries (SCI).[NCT03979742] | Phase 2 | 18 participants (Anticipated) | Interventional | 2022-02-22 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for amantadine and Peripheral Nervous System Diseases
| Article | Year |
|---|---|
N-methyl-D-aspartate antagonists and neuropathic pain: the search for relief.
Topics: Analgesics; Analgesics, Opioid; Animals; Binding Sites; Glycine; Humans; Ion Channel Gating; Pain; P | 2007 |
Interventions for fatigue in peripheral neuropathy.
Topics: Adult; Amantadine; Ascorbic Acid; Charcot-Marie-Tooth Disease; Child; Fatigue; Guillain-Barre Syndro | 2014 |
7 other studies available for amantadine and Peripheral Nervous System Diseases
| Article | Year |
|---|---|
Clinical and Electrophysiological Features of Chronic Motor Axonal Neuropathy.
Topics: Amantadine; Amyotrophic Lateral Sclerosis; Electrophysiological Phenomena; Humans; Motor Neurons; Mu | 2022 |
[Peripheral polyneuropathy and bilateral optic neuropathy during treatment of chronic hepatitis C].
Topics: Adrenal Cortex Hormones; Amantadine; Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis | 2009 |
Systemic agmatine attenuates tactile allodynia in two experimental neuropathic pain models in rats.
Topics: Amantadine; Analgesics, Non-Narcotic; Animals; Diabetic Neuropathies; Female; Ligation; Male; Pain; | 2003 |
Combined therapy with clonidine and amantadine may act in two stages of glutamate-mediated neuropathic pain caused by a needle puncture in an upper extremity.
Topics: Adrenergic alpha-Agonists; Adult; Amantadine; Analgesics, Non-Narcotic; Calcium Channel Blockers; Ca | 2005 |
Amantadine-induced peripheral neuropathy.
Topics: Amantadine; Antiparkinson Agents; Chronic Disease; Female; Humans; Leg; Middle Aged; Muscle Weakness | 1999 |
Amantadine-induced peripheral neuropathy.
Topics: Amantadine; Dopamine Agents; Humans; Peripheral Nervous System Diseases | 2000 |
Dysaesthesia-dyskinesia: a syndrome of painful legs and moving toes.
Topics: Aged; Amantadine; Amitriptyline; Chlorpromazine; Dihydroxyphenylalanine; Female; Humans; Leg; Moveme | 1973 |